Chemotargets is a computationally-oriented biotech company focused on the drug discovery and development areas.
Chemotargets – predicting the target and safety profile of small molecules
Chemotargets’ goal is to help the biopharma industry fast-forward the process of bringing new medicines to market, speeding up drug discovery and development programs and making them more cost-efficient. To this end, Chemotargets has designed, and continues developing, an integrated technology platform involving a broad spectrum of cutting-edge computational methodologies. CTlink is Chemotargets’ platform-independent software for large scale off-target pharmacology and predictive safety of small molecule pharmaceuticals, cosmeceuticals, agrochemicals, and environmental pollutants. CTlink is a systems discovery package designed as a modular computational framework that, in every execution, links together different input and output spaces through appropriate connections (LINKs); molecules, biological targets, safety endpoints, etc… To date, two different LINKs have been implemented so far: Molecule-Target LINK (TLINK) and Molecule-Safety LINK (SLINK). Chemotargets has just launched a graphical user interface for CTlink, its software for predicting the target and safety profile of small molecules. It has been specially designed to be used by chemists, pharmacologists, toxicologists, company managers, etc… so they can draw a molecule or upload a file, submit the CTlink calculation to predict the targets, and visualize the results in an intuitive and integrated manner.
Located in Barcelona (Spain), it was founded on March 2006 as a spin-off initiative from the Chemogenomics Laboratory under the auspices of the Municipal Institute of Medical Research (IMIM-Hospital del Mar). Since 2006, Chemotargets has provided computational drug discovery services to a great number pharmaceutical and biotech companies and carried out collaboration agreements with different academic and research institutions. In addition, Chemotargets is currently participating in three different EU funded research projects; eTOX, focused on the in silico prediction of in vivo toxicities associated with drugs and drug candidates, CHAARM, focused on the development of combinations of highly active specifically-targeted microbicides for vaginal and rectal application and MICROSMETICS, focused on the discovery and development of novel cosmeceutical agents.
More about Chemotargets : www.chemotargets.com